Harry Bushe, M.S.

Graduate School

1986 M.S. University of Lowell

Accreditation

1997 American Board of Radiology

Academic Appointment

Instructor

Peer Reviewed Journal Papers

  • Siochi RA, Balter P, Bloch CD, Bushe HS, Mayo CS, Curran BH, Feng W, Kagadis GC, Kirby TH, Stern RL.Information technology resource management in radiation oncology. J Appl Clin Med Phys. 2009 Sep 2;10(4):3116.
  • Das IJ, Copeland JF, Bushe HS: Spatial distribution of bremsstrahlung in a dual electron beam used in total skin electron irradiation: errors due to ionization chamber cable irradiation. Med Phys, 21(11):1733-8, 1994 Nov..
  • Das IJ, Bushe HS: Backscattering and transmission through a high Z interface as a measure of electron beam energy. Med Phys, 21 (2):315-9, 1994 Feb..
  • Das IJ, Bushe HS, Copeland JF: Determination of exact point of measurement and surface dose in an electron beam with a cylindrical ion chamber. Association of Medical Physicists of India, Medical Physics Bulletin, 18: 2, 1993.
  • Jusko W, Bushe HS, Brill AB, Schmetler R: Immunopharmacokinetics and radiation dosimetry of In-111 CYT-103. In Oncoscint Cancer Imaging. Published by Cytogen Inc..
  • Hnatowich DJ, Mardirossian G, Rusckowski M, Roy S, Bushe H, Griffin TW, Brill AB: Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labeled with technetium-99m and indium-111: a comparison in patients. Nuc Med Commun, 14(1):52-63, 1993 Jan..
  • Aas M, Mardirossian G, Griffin TW, Aalimi AR, Ito T, Bushe HS, Atcher RW, Hines JJ, Brill AB, Hnatowich DJ: Long-term biodistribution in tumored mice of murine and chimeric B72.3 IgG antibody radiolabeled with 114m-In via both DTPA and a macrocyclic chelator. Journal of Nuclear Biology & Medicine. 36 (1):33-40, 1992 Jan.-Mar..
  • Hnatowich DJ, Ruskowski M, Siebecker DA, Gionet M, Bushe HS, Mattis JA, Shealey D, Griffin TW, Brill AB: Pharmacokinetics of Indium-111 labaled 10-3d2 antibreast tumor antibody in patients. Journal of Nuclear Biology & Medicine. 36 (1):7-13, 1992 Jan.-Mar..
  • Griffin TW, Brill AB, Stevens S, Collins JA, Bokhari F, Bushe H, Stochl MC, Gionet M, Rusckowski M, Stroupe SD; “Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer”. Journal of Clinical Oncology, 9(4):631-40, 1991 Apr..
  • Rescigno A, Brill AB, Bushe HS, Hnatowich DJ: Comments on “Compartmental biodistribution of a monoclonal antibody against human lung adenocarcinoma grown in athymic mice”. International Journal of Radiation Applications & Instrumentation – Part B, Nuclear Medicine & Biology. 18(3):367-8 1991 (Letter).
  • Penney BC, Rajeevan N, Bushe HS, Hademenos G, King MA, de Vries DJ, Moore SC: A scatter reduction method for In-111 scintigrams using five energy windows, In: Conf. Record of 1991 IEEE Nucl. Sci. Symp. and Medical Imaging Conf., IEEE Service Center, Piscataway, NJ, pp.1866-1873, 1991.
  • Hnatowich DJ, Ruskowski M, Brill AB, Siebecker DA, Misra H, Mardirossian G, Bushe HS, Rescigno A, Stevens, S, Johnson DK, Griffin TW: Pharmacokinetics in patients of an anti-cea antibody radiolabeled with 111-In using a novel DTPA chelator. Can. Res. 50: 7272-7228, 1990.
  • Rescigno A, Bushe HS, Brill AB, Rusckowski M, Griffin TW, Hnatowich DJ: Pharmacokinetic modeling of radiolabeled antibody distribution in man. Am. J. Phys. Im. 5: 141-150, 1990.